RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced that abstracts featuring lorundrostat clinical data from both Phase 2 and Phase 1 studies have been selected for a moderated poster presentation and poster presentation at the American College of Cardiology’s 72nd Annual Scientific Session together with the World Congress of Cardiology (ACC.23/WCC), which is scheduled to take place in New Orleans, LA, on March 4-6, 2023.
Mineralys Poster Details:
| Moderated Poster Title: | Highly Effective Blood Pressure Lowering with lorundrostat, a New Aldosterone Synthase Inhibitor, in Individuals with Obesity and RAAS Dysregulation |
| Presenter Name: | David Rodman, MD, FAHA |
| Session Title: | Treating the Whole Patient including Comorbidities |
| Presentation Number: | 1029-05 |
| Presentation Time and Date: | 3:15 p.m. – 3:25 p.m. CT on Saturday, March 4, 2023 |
| Session Location: | Heart Failure and Cardiomyopathies Moderated Poster Theater 9, Hall F |
| Poster Presentation Title: | First-In-Human Study of lorundrostat, a Potent and Highly Selective Aldosterone Synthase Inhibitor |
| Presenter Name: | David Rodman, MD, FAHA |
| Session Title: | Heart Failure and Cardiomyopathies: Clinical Science 11 |
| Presentation Number: | 1560-160 |
| Presentation Time: | 12:45 p.m. – 1:30 p.m. CT on Sunday, March 5, 2023 |
| Session Location: | Poster Hall, Hall F |
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.
Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.